← FDA DRUG APPROVALS

FDA ANDA · ANDA084772

PROMETH FORTIS

Sponsor: ALPHARMA US PHARMS

APPLICATION
ANDA084772
TYPE
ANDA
ORIGINAL APPROVAL
1978-11-14
LATEST ACTION
1990-04-18
ROUTE
ORAL
DOSAGE FORM
SYRUP
MARKETING STATUS
Discontinued

Products

PROMETH FORTISDiscontinued
PROMETHAZINE HYDROCHLORIDE 25MG/5ML · SYRUP · ORAL

Approval history

1990-04-18Labeling · Supplement 20AP
1989-11-28Labeling · Supplement 19AP
1988-09-27Labeling · Supplement 16AP
1988-06-06Labeling · Supplement 15AP
1978-11-14OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →